Sabine Vogler

Sabine Vogler publication distribution in Economics and Finance in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Economics and Finance in 2026. The highlighted bar marks where Sabine Vogler sits on this spectrum.

Sabine Vogler D-index placement in Economics and Finance in 2026

The chart shows the D-index (discipline H-index) distribution of Economics and Finance scientists ranked by Research.com in 2026. The highlighted bar marks where Sabine Vogler sits on this spectrum.

Best Publications

• Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.

  Swathi Iyengar;Kiu Tay-Teo;Sabine Vogler;Peter Beyer

  283
  Citations

• European collaborations on medicine and vaccine procurement.

  Sabine Vogler;Manuel A Haasis;Rianne van den Ham;Tifenn Humbert

  219
  Citations

• Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

  Sabine Vogler;Agnes Vitry;Zaheer Ud Din Babar

  206
  Citations

• Introduction to drug utilization research

  Unknown

  206
  Citations

• Pharmaceutical policies in European countries in response to the global financial crisis.

  Sabine Vogler;Nina Zimmermann;Christine Leopold;Kees de Joncheere

  198
  Citations

• How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries

  Sabine Vogler;Valérie Paris;Alessandra Ferrario;Veronika J. Wirtz

  185
  Citations

• How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries

  Sabine Vogler;Valérie Paris;Alessandra Ferrario;Veronika J. Wirtz

  185
  Citations

• Differences in external price referencing in Europe: a descriptive overview.

  Christine Leopold;Sabine Vogler;A.K. Mantel-Teeuwisse;Kees de Joncheere

  177
  Citations

• Medication wasted – Contents and costs of medicines ending up in household garbage

  Unknown

  165
  Citations

• Pharmaceutical regulation in 15 European countries review.

  Dimitra Panteli;Francis Arickx;Irina Cleemput;Guillaume Dedet

  158
  Citations

• Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

  Kim Pauwels;Isabelle Huys;Sabine Vogler;Minne Casteels

  153
  Citations

• The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview

  Unknown

  111
  Citations

• Payers' experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia.

  Steven G. Morgan;Sabine Vogler;Anita K. Wagner

  97
  Citations

• Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States

  Sabine Vogler;Claudia Habl;Martina Bogut;Luka Vončina

  86
  Citations

• Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries

  Sabine Vogler;Katharina Habimana;Danielle Arts

  83
  Citations

• Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure.

  Sabine Vogler;Peter Schneider;Martin Zuba;Reinhard Busse

  77
  Citations

• Discounts and rebates granted to public payers for medicines in European countries.

  Unknown

  70
  Citations

• The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices

  Panos Kanavos;Willemien Schurer;Sabine Vogler

  67
  Citations

• Medicines reimbursement policies in Europe

  Sabine Vogler;Manuel Alexander Haasis;Guillaume Dedet;Janice Lam

  55
  Citations

• Strategies to achieve fairer prices for generic and biosimilar medicines

  Alessandra Ferrario;Guillaume Dedet;Tifenn Humbert;Sabine Vogler

  46
  Citations